Vascular Brachytherapy with<sup>192</sup>Ir after Femoropopliteal Stent Implantation in High-Risk Patients: Twelve-month Follow-up Results from the Vienna-5 Trial
Roswitha Wolfram(Vienna General Hospital), Erich Minar(Medical University of Vienna), Boris Pokrajac(Vienna General Hospital), Alexandra C. Budinsky(Medical University of Vienna), Richard Pötter(Medical University of Vienna)
Cited by 23
Related Papers
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
|Radiotherapy and Oncology|2006|1.6k
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
|Radiotherapy and Oncology|2005|1.6k
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765